domingo, 8 de octubre de 2023

Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future L Szczerbinski et al. The Lancet Diabetes Endocr, October 4, 2023

From the abstract: " In this Review, we discuss advances in the genetics of obesity from the past decade—with emphasis on developments from the past 5 years—with a focus on metabolic consequences, and their potential implications for precision management of the disease. We also provide an overview of the potential role of genetics in guiding weight loss strategies. Finally, we propose a vision for the future of precision obesity management." https://phgkb.cdc.gov/PHGKB/phgHome.action?query=Obesity&action=search&Mysubmit=Search

No hay comentarios:

Publicar un comentario